首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
【24h】

Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.

机译:成人社区性发热性尿路感染的成人对氟喹诺酮类耐药的大肠杆菌的危险因素。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVES: To assess risk factors for fluoroquinolone resistance in community-onset febrile Escherichia coli urinary tract infection (UTI). METHODS: A nested case-control study within a cohort of consecutive adults with febrile UTI presenting at primary healthcare centres or emergency departments during January 2004 through December 2009. Resistance was defined using EUCAST criteria (ciprofloxacin MIC >1.0 mg/L). Cases were subjects with fluoroquinolone-resistant E. coli, and controls those with fluoroquinolone-susceptible isolates. Multivariable logistic regression analysis was used to identify potential risk factors for fluoroquinolone resistance. RESULTS: Of 787 consecutive patients, 420 had E. coli-positive urine cultures. Of these, 51 (12%) were fluoroquinolone resistant. Independent risk factors for fluoroquinolone resistance were urinary catheter [odds ratio (OR) 3.1; 95% confidence interval (CI) 0.9-11.6], recent hospitalization (OR 2.0; 95% CI 1.0-4.3) and fluoroquinolone use in the past 6 months (OR 17.5; 95% CI 6.0-50.7). Environmental factors (e.g. contact with animals or hospitalized household members) were not associated with fluoroquinolone resistance. Of fluoroquinolone-resistant strains, 33% were resistant to amoxicillin/clavulanate and 65% to trimethoprim/sulfamethoxazole; 14% were extended-spectrum beta-lactamase (ESBL) positive compared with <1% of fluoroquinolone-susceptible isolates. CONCLUSIONS: Recent hospitalization, urinary catheter and fluoroquinolone use in the past 6 months were independent risk factors for fluoroquinolone resistance in community-onset febrile E. coli UTI. Contact with animals or hospitalized household members was not associated with fluoroquinolone resistance. Fluoroquinolone resistance may be a marker of broader resistance, including ESBL positivity.
机译:目的:评估社区发病性发热性大肠杆菌泌尿道感染(UTI)中氟喹诺酮耐药的危险因素。方法:从2004年1月至2009年12月,在初级保健中心或急诊科就诊的连续成人热性尿路感染成人队列研究中,采用嵌套病例对照研究。耐药性采用EUCAST标准(环丙沙星MIC> 1.0 mg / L)定义。病例为对氟喹诺酮耐药的大肠杆菌,对照为对氟喹诺酮敏感的分离株。多变量logistic回归分析用于确定氟喹诺酮耐药性的潜在危险因素。结果:连续787例患者中,有420例具有大肠杆菌阳性尿培养。其中,51例(12%)耐氟喹诺酮。氟喹诺酮耐药的独立危险因素是导尿管[比值比(OR)3.1; 95%置信区间(CI)0.9-11.6],近期住院治疗(OR 2.0; 95%CI 1.0-4.3)和过去6个月内使用氟喹诺酮(OR 17.5; 95%CI 6.0-50.7)。环境因素(例如与动物或住院的家庭成员接触)与氟喹诺酮耐药性无关。在氟喹诺酮耐药菌株中,阿莫西林/克拉维酸盐耐药菌株为33%,甲氧苄啶/磺胺甲恶唑耐药菌株为65%。 14%的超广谱β-内酰胺酶(ESBL)阳性,而小于1%的氟喹诺酮敏感性分离物。结论:最近住院,最近六个月内使用导尿管和氟喹诺酮是社区性发热性大肠杆菌UTI中氟喹诺酮耐药的独立危险因素。与动物或住院的家庭成员接触与氟喹诺酮耐药无关。氟喹诺酮耐药性可能是更广泛耐药性的标志,包括ESBL阳性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号